Nausea, vomiting, and digestive discomfort were still the most common side effects
Howard Goodwin, DNAP, CRNA, CHSE, is dedicated to helping you reach your weight management goals safely and effectively
For Canadian researchers who want to review both options directly, see the retatrutide page and the tesamorelin page
The phase 2 trial record for NCT03856047 prespecifies exactly how timing deviations were handled
However, there is one case report of life-threatening eosinophilic pleuropericardial effusion in an elderly woman who took a combination of 10 mg/day of biotin and 300 mg/day of pantothenic acid for two months (44)
Tirzepatide Shortage Resolution and Its Impact The FDA officially resolved the tirzepatide injection shortage in October 2025, following Eli Lilly's expansion of manufacturing capacity at its new $2.5 billion facility in Lebanon, Indiana [3]